DK113291B - Fremgangsmåde til fremstilling af coronardilatatorisk virksomme diazacycloalkanforbindelser eller syreadditionssalte deraf. - Google Patents
Fremgangsmåde til fremstilling af coronardilatatorisk virksomme diazacycloalkanforbindelser eller syreadditionssalte deraf.Info
- Publication number
- DK113291B DK113291B DK620966AA DK620966A DK113291B DK 113291 B DK113291 B DK 113291B DK 620966A A DK620966A A DK 620966AA DK 620966 A DK620966 A DK 620966A DK 113291 B DK113291 B DK 113291B
- Authority
- DK
- Denmark
- Prior art keywords
- dilatatorically
- coronary
- active
- preparation
- acid addition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
- C07D245/02—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1965A0051095 DE1545575C2 (de) | 1965-12-16 | 1965-12-16 | N, N'-Bis- eckige Klammer auf 3"(3', 4', 5'-trimethoxybenzoyloxy)-propyl eckige Klammer zu -homopiperazin |
Publications (1)
Publication Number | Publication Date |
---|---|
DK113291B true DK113291B (da) | 1969-03-10 |
Family
ID=6937763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK620966AA DK113291B (da) | 1965-12-16 | 1966-12-01 | Fremgangsmåde til fremstilling af coronardilatatorisk virksomme diazacycloalkanforbindelser eller syreadditionssalte deraf. |
Country Status (14)
Country | Link |
---|---|
US (1) | US3532685A (cs) |
AT (1) | AT275527B (cs) |
BE (1) | BE691016A (cs) |
CH (1) | CH476742A (cs) |
CS (1) | CS191151B2 (cs) |
DE (1) | DE1545575C2 (cs) |
DK (1) | DK113291B (cs) |
ES (1) | ES334393A1 (cs) |
FR (1) | FR6053M (cs) |
GB (1) | GB1107470A (cs) |
IL (1) | IL27013A (cs) |
MY (1) | MY7100027A (cs) |
NL (1) | NL153537B (cs) |
SE (1) | SE317977B (cs) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3980643A (en) * | 1974-01-04 | 1976-09-14 | Hokuriku Pharmaceutical Co., Ltd. | Novel piperazine- and homopiperazine-monoalkanol esters and a process of production thereof |
US4035494A (en) * | 1975-10-20 | 1977-07-12 | Sandoz, Inc. | Bis-p-pivaloyl benzylamines |
DE3403778A1 (de) * | 1984-02-03 | 1985-08-08 | Degussa Ag, 6000 Frankfurt | Cyanomethyl-(2-cyano-ethyl)-(3-hydroxy-propyl)-amin seine verwendung zur herstellung von 1-(3-hydroxy-propyl)-1,4-diazepan und 1,4-bis(3-(3,4,5-trimethoxybenzoyloxy)-propyl)-diazepan |
JPS60258118A (ja) * | 1984-06-06 | 1985-12-20 | Kowa Co | 抗動脈硬化剤 |
DE3438289A1 (de) * | 1984-10-19 | 1986-04-24 | Degussa Ag, 6000 Frankfurt | Verfahren zum reinigen von dilazep-base |
AP2005003232A0 (en) | 2002-08-19 | 2005-03-31 | Pfizer Prod Inc | Combination therapy for hyperproliferative diseases. |
US20060063803A1 (en) * | 2004-09-23 | 2006-03-23 | Pfizer Inc | 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
ES2382009T3 (es) | 2006-12-01 | 2012-06-04 | Bristol-Myers Squibb Company | Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares |
CN105143203A (zh) | 2013-04-17 | 2015-12-09 | 辉瑞大药厂 | 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物 |
WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
WO2020150473A2 (en) | 2019-01-18 | 2020-07-23 | Dogma Therapeutics, Inc. | Pcsk9 inhibitors and methods of use thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE629910A (cs) * | 1962-03-22 | |||
DE1182239B (de) * | 1962-04-02 | 1964-11-26 | Lentia Gmbh | Verfahren zur Herstellung von Piperazinderivaten |
-
1965
- 1965-12-16 DE DE1965A0051095 patent/DE1545575C2/de not_active Expired
-
1966
- 1966-12-01 DK DK620966AA patent/DK113291B/da unknown
- 1966-12-02 GB GB54090/66A patent/GB1107470A/en not_active Expired
- 1966-12-05 AT AT1120566A patent/AT275527B/de active
- 1966-12-05 IL IL27013A patent/IL27013A/xx unknown
- 1966-12-07 US US599724A patent/US3532685A/en not_active Expired - Lifetime
- 1966-12-10 ES ES0334393A patent/ES334393A1/es not_active Expired
- 1966-12-12 SE SE17000/66A patent/SE317977B/xx unknown
- 1966-12-12 BE BE691016D patent/BE691016A/xx not_active IP Right Cessation
- 1966-12-14 CS CS668008A patent/CS191151B2/cs unknown
- 1966-12-15 NL NL666617653A patent/NL153537B/xx not_active IP Right Cessation
- 1966-12-15 CH CH1789566A patent/CH476742A/de not_active IP Right Cessation
- 1966-12-16 FR FR87720A patent/FR6053M/fr not_active Expired
-
1971
- 1971-12-31 MY MY197127A patent/MY7100027A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CH476742A (de) | 1969-08-15 |
IL27013A (en) | 1970-07-19 |
FR6053M (cs) | 1968-05-20 |
DE1545575B1 (de) | 1970-02-05 |
CS191151B2 (en) | 1979-06-29 |
US3532685A (en) | 1970-10-06 |
AT275527B (de) | 1969-10-27 |
BE691016A (cs) | 1967-06-12 |
DE1545575C2 (de) | 1970-09-10 |
SE317977B (cs) | 1969-12-01 |
GB1107470A (en) | 1968-03-27 |
NL153537B (nl) | 1977-06-15 |
MY7100027A (en) | 1971-12-31 |
ES334393A1 (es) | 1967-11-01 |
NL6617653A (cs) | 1967-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK114981B (da) | Fremgangsmåde til fremstilling af basisk substituerede phthalaner eller iso-chromaner eller syreadditionssalte deraf. | |
DK105765C (da) | Fremgangsmåde til fremstilling af quinazolon-derivater eller syreadditionssalte deraf. | |
DK115847B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive 2,4-diamino-5-benzyl-pyrimidinderivater eller syreadditionssalte deraf. | |
DK114629B (da) | Fremgangsmåde til fremstilling af 1-substituerede nitroimidazolforbindelser eller syreadditionssalte deraf. | |
DK121905C (da) | Fremgangsmåde til fremstilling af N-alkylminoalkylderivater af spirotetralinsuccinimider eller syreaddionssalte deraf. | |
DK120341B (da) | Analogifremgangsmåde til fremstilling af benzoxacinforbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser heraf. | |
DK113291B (da) | Fremgangsmåde til fremstilling af coronardilatatorisk virksomme diazacycloalkanforbindelser eller syreadditionssalte deraf. | |
DK127599B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 2,4-diaminosubstituerede quinazolin-forbindelser eller syreadditionssalte heraf. | |
DK119059B (da) | Fremgangsmåde til fremstilling af 2-nitro-imidazolderivater eller syreadditionssalte deraf. | |
DK117427B (da) | Fremgangsmåde til fremstilling af phenoxypropanolaminer eller syreadditionssalte deraf. | |
DK119774B (da) | Fremgangsmåde til fremstilling af antitussivt aktive 4-substituerede 2-benzhydryl-2-butanol-derivater eller syreadditionssalte deraf. | |
DK121606B (da) | Fremgangsmåde til fremstilling af substituerede piperaziner eller syreadditionssalte deraf. | |
DK111489B (da) | Fremgangsmåde til fremstilling af benzodiazepinderivater eller 4-oxider eller syreadditionssalte deraf. | |
DK129924B (da) | Analogifremgangsmåde til fremstilling af aminoalkylaminobenzophenonderivater eller syreadditionssalte deraf. | |
DK117636B (da) | Fremgangsmåde til fremstilling af diazocin- eller diazecinderivater eller syreadditionssalte deraf. | |
DK106335C (da) | Fremgangsmåde til fremstilling af derivater af 16-hydroxymethylenyohimbanforbindelser eller syreadditionssalte deraf. | |
DK103831C (da) | Fremgangsmåde til fremstilling af 4-azathioxanthenderivater eller syreadditionssalte deraf. | |
DK107875C (da) | Fremgangsmåde til fremstilling af heterocykliske sulfonylcarbaminsyrederivater eller syreadditionssalte deraf. | |
DK115842B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive substituerede 4-aminobutynylsuccinimider eller 4-aminobutynylglutarimider eller syreadditionssalte deraf. | |
DK115840B (da) | Fremgangsmåde til fremstilling af phenylcyclohexylalkylaminer eller syreadditionssalte deraf. | |
DK113077B (da) | Fremgangsmåde til fremstilling af basiske ethano-anthracenderivater eller syreadditionssalte deraf. | |
DK121604B (da) | Fremgangsmåde til fremstilling af substituerede iminocycloheptatrienderivater eller syreadditionssalte heraf. | |
DK114406B (da) | Fremgangsmåde til fremstilling af hjerte-kredsløbaktive phenyl-propylaminer eller syreadditionssalte deraf. | |
DK116211B (da) | Fremgangsmåde til fremstilling af acridanderivater eller syreadditionssalte deraf. | |
DK122877B (da) | Analogifremgangsmåde til fremstilling af fenylisopropylalkylaminderivater eller syreadditionssalte deraf. |